You are viewing: Europe Home Healthcare Market analysis
Part of: Home Healthcare Market (Global)

The Europe Home Healthcare Market was valued at $357.5 Million in 2025 and projected to reach to $492.5 Million by 2030, representing a compound annual growth rate of 6.6%. Europe's home healthcare ventilators market is poised for sustained growth through 2030, driven by an aging population, rising prevalence of chronic respiratory diseases, and healthcare systems' shift toward home-based care delivery.

Europe Home Healthcare Market Trends and Insights

  • Ventilators represent a critical component of home-based respiratory care, enabling patients with chronic respiratory conditions to maintain independence while receiving necessary medical support.
  • The expansion of Ventilators adoption reflects increasing demand for portable, user-friendly respiratory devices that allow patients to manage conditions such as COPD, neuromuscular disorders, and post-acute care needs in home settings. Driving this growth, Ventilators benefit from technological advancements in miniaturization, battery efficiency, and connectivity features that enhance patient compliance and clinical outcomes.
  • The aging global population and rising prevalence of respiratory diseases continue to fuel demand for Ventilators in home healthcare environments.
  • Between 2025 and 2030, Ventilators are expected to capture growing market share as healthcare systems shift toward cost-effective, patient-centered care models that prioritize home-based treatment over institutional settings..

Key Market Statistics

  • CAGR (2025-2030) 6.6% CAGR
  • Market Size, 2025 ~USD 357.5 Million
  • Forecast, 2030 ~USD 492.5 Million
  • Geography Europe

Europe Home Healthcare Market Overview

Strong Regional Growth Trajectory :

Europe's home healthcare market is expanding at a 6.6% CAGR, with the ventilators segment growing from $357.5 million in 2025 to $492.5 million by 2030, reflecting increasing adoption of respiratory care solutions across the region.

Germany Leads European Market :

Germany dominates Europe's home healthcare sector with a market size of $40.8 billion, followed by the UK at $25.4 billion, positioning these nations as key growth drivers for ventilator technology and respiratory care innovation.

Aging Population Driving Demand :

Europe's aging demographic profile is accelerating demand for home-based ventilator solutions, as healthcare systems prioritize cost-effective, patient-centric care models that enable chronic respiratory patients to maintain independence at home.

Regulatory Support & Healthcare Integration :

Stringent European healthcare regulations and integrated reimbursement frameworks are fostering market maturity, with established medical device standards ensuring quality ventilator solutions and supporting sustainable market expansion across member states.

Europe Home Healthcare Market Dynamics

  • The region's advanced healthcare infrastructure and strong regulatory frameworks create a favorable environment for innovative ventilator technologies.
  • Germany, the UK, France, and Italy represent significant growth opportunities, with increasing reimbursement support and patient preference for home care solutions.
  • Market expansion will be supported by technological advancements in portable and user-friendly ventilator designs, enhanced telemedicine integration, and growing awareness among healthcare providers about cost-effective respiratory care management at home..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Ventilators segment valued at $357.5M in 2025, growing to $492.5M by 2030 at 6.6% CAGR
    • Ventilators enable chronic respiratory patients to receive care independently in home settings
    • Technological innovations in Ventilators drive adoption through improved portability and connectivity
    • Ventilators benefit from demographic shifts toward aging populations with increased respiratory disease prevalence

    Home Healthcare Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment INSULIN DELIVERY DEVICES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.9% from 2025 to 2030
    Largest Segment THERAPEUTIC PRODUCTS (Product)
    Market Size Base Year (Billions) ~USD 309.35 (2025)
    Revenue Forecast (Billions) ~USD 473.8 (2030)
    Segments Covered Product, Type, Product & Service

    Europe Home Healthcare Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Mobility Care Products
    • Testing, Screening, & Monitoring Products
    • Testing, Screening, And Monitoring Products
    • Therapeutic Products

    By Type

    • Activity Monitors & Wrist Bands
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Cancer
    • Canes
    • Cardiovascular Diseases & Hypertension
    • Cardiovascular Disorders & Hypertension
    • Cholesterol Testing Products
    • Coagulation Monitoring Products
    • Colon Cancer Test Kits
    • Crutches
    • Diabetes
    • Dialysis Equipment
    • Drug & Alcohol Test Kits
    • Ecg/Ekg Devices
    • Eeg Devices
    • Fetal Monitoring Devices
    • Hearing Aids
    • Hearing Disorders
    • Heart Rate Monitors
    • Hiv Test Kits
    • Holter & Event Monitors
    • Home Hba1C Test Kits
    • Home Hemoglobin A1C Test Kits
    • Home Sleep Testing Devices
    • Hospice & Palliative Care Services
    • Hospice And Palliative Care Services
    • Infusion Therapy Services
    • Inhalers
    • Insulin Delivery Devices
    • Iv Equipment
    • Mobility Disorders
    • Mobility Scooters
    • Nebulizers
    • Other Indications
    • Other Therapeutic Products
    • Ovulation & Pregnancy Test Kits
    • Oxygen Delivery Systems
    • Peak Flow Meters
    • Pregnancy
    • Pregnancy Care Services
    • Pulse Oximeters
    • Rehabilitation Therapy Services
    • Respiratory Diseases
    • Respiratory Therapy Services
    • Skilled Nursing Services
    • Sleep Apnea Therapeutic Devices
    • Temperature Monitoring Devices
    • Unskilled Care Services
    • Ventilators
    • Walkers & Rollators
    • Wheelchairs
    • Wound Care
    • Wound Care Products

    By Product & Service

    • Product
    • Service

    Target Audience

    • Medical Device Manufacturers : Ventilator and respiratory equipment manufacturers need Europe-specific market data to develop localized product strategies, identify distribution partnerships, and optimize pricing for different European healthcare systems.
    • Healthcare Providers & Hospital Networks : European hospitals and home healthcare providers require market insights to plan procurement strategies, understand competitive offerings, and align home ventilator programs with regional reimbursement and clinical guidelines.
    • Healthcare Investors & Private Equity : Investment firms targeting European healthcare need detailed market forecasts and country-level data to evaluate acquisition targets, assess growth potential, and structure deals in the expanding home healthcare ventilators segment.
    • Healthcare Policy & Government Bodies : European health ministries and regulatory agencies use market research to inform healthcare policy, reimbursement frameworks, and medical device regulations that shape the ventilators market landscape.
    • Distributors & Healthcare Suppliers : Medical device distributors and suppliers across Europe need regional market intelligence to identify growth opportunities, negotiate with manufacturers, and develop effective sales strategies for home ventilator solutions.

    Key Companies in the Europe Home Healthcare Market

    CompanyHQOwnershipStrongest segments
    FISHER & PAYKEL HEALTHCAREUnited StatesPublic CompanyTherapeutic (CPAP, humidification, respiratory support devices),Monitoring, Testing, Screening (OSA and respiratory-related),Mobility Care and accessories,
    NOVO NORDISK A/SDenmarkPublic CompanyTherapeutic (insulins, GLP-1, obesity and rare disease therapies used at home),Testing, Screening, Monitoring (digital dose guidance, data connectivity around pens),Mobility Care,
    APRIA HEALTHCARE GROUP, INCUnited StatesPrivate CompanyTherapeutic (respiratory, sleep apnea, NPWT, other HME),Testing, Screening, Monitoring,Mobility Care and other HME,
    CONMED CORPORATIONUnited StatesPublic CompanyTherapeutic (home-use relevant),Testing, Screening, Monitoring,Mobility Care,
    CONSORT MEDICALUnited KingdomPrivate CompanyTherapeutic (drug delivery devices for home use),Testing, Screening & Monitoring–linked devices,Mobility Care–adjacent components,
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic products for home use,Testing, screening, and monitoring,Mobility care and durable equipment,
    HILL-ROM HOLDINGS, INC.United StatesPrivate CompanyTherapeutic (incl. respiratory and non-invasive therapeutic surfaces),Mobility Care (beds, lifts, patient mobility solutions for home),Testing, Screening & Monitoring,
    JABILUnited StatesPublic CompanyTherapeutic devices (home-use),Testing, Screening & Monitoring devices,Mobility care hardware,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyMonitoring (BP monitors, thermometers, oximeters, scales),Therapeutic & Respiratory (nebulizers, suction units, aero spacers, heating pads, anti-decubitus mattresses),Testing & Screening (blood glucose systems, peak flow meters),
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyTherapeutic (home dialysis equipment, solutions, consumables),Testing, Screening, Monitoring,Mobility Care,
    ABBOTTUnited StatesPublic CompanyTesting, Screening, and Monitoring,Therapeutic,Mobility Care,
    LINDE PLCUnited KingdomPublic CompanyTherapeutic (home oxygen, respiratory support),Testing, Screening, Monitoring,Mobility Care,
    RESMEDUnited StatesPublic CompanyTherapeutic (home respiratory and sleep therapy devices),Testing & Screening (home sleep diagnostics),Monitoring (remote patient monitoring and analytics),
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic (incl. sleep and respiratory care, home ventilation),Testing, Screening, Monitoring (remote patient monitoring, diagnostics at home),Mobility Care and Personal Health Devices,
    GE HEALTHCAREUnited StatesPublic CompanyMonitoring (vital signs, diagnostic cardiology, maternal-infant),Testing, Screening & Imaging-linked Home Pathways,Therapeutic & Infusion-linked Solutions,
    A&D HOLON HOLDINGS COMPANY, LIMITEDJapanPublic CompanyTesting, Screening, and Monitoring Devices,Therapeutic Devices (Ultrasonic Inhalers),Mobility Care,
    CONVATEC GROUP PLCUnited KingdomPublic CompanyTherapeutic products (wound, ostomy, continence, infusion sets) used at home,Monitoring / testing interfaces linked to infusion and chronic care,Mobility and home-care accessories for chronic-condition management,
    AMEDISYSUnited StatesPrivate CompanyTherapeutic (home-based therapies, including infusion support),Testing, Screening, Monitoring (clinical assessments, remote oversight),Mobility Care (rehabilitation, PT/OT, functional support),
    INVACARE CORPORATIONUnited StatesPrivate CompanyMobility Care (power and manual wheelchairs, ramps),Therapeutic & Lifestyle (pressure-relief, beds, safe patient handling),Testing, Screening & Monitoring (heart rate monitors, thermometers),
    SUNRISE MEDICALUnited StatesPrivate CompanyMobility Care (manual & power wheelchairs, scooters),Therapeutic & Rehabilitation Products (seating, positioning),Testing, Screening, Monitoring & Other,

    FISHER & PAYKEL HEALTHCARE

    Fisher & Paykel Healthcare is a publicly traded medical device company founded in 1934 and headquartered in the United States. With 7,396 employees, the company designs and manufactures healthcare products and systems.

    NOVO NORDISK A/S

    Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 and publicly listed on stock exchanges. The company employs 67,900 people and focuses on biopharmaceutical research and development.

    APRIA HEALTHCARE GROUP, INC

    Appia Healthcare Group, Inc. is a privately held U.S. healthcare company founded in 2018 with 6,250 employees. The company provides healthcare services and solutions to patients and providers.

    CONMED CORPORATION

    CONMED Corporation is a publicly traded medical technology company founded in 1970 and based in the United States. With 3,900 employees, the company manufactures surgical and patient monitoring equipment.

    CONSORT MEDICAL

    Consort Medical is a privately held British medical device company founded in 1938 with 2,000 employees. The company develops and manufactures drug delivery and diagnostic devices.

    HENRY SCHEIN

    Henry Schein is a publicly traded healthcare company founded in 1932 and headquartered in the United States. With 25,000 employees, the company distributes medical, dental, and veterinary products and services.

    HILL-ROM HOLDINGS, INC.

    Hill-Rom Holdings, Inc. is a privately held medical technology company founded in 1915 and based in the United States. The company employs 10,000 people and manufactures patient care equipment and solutions.

    JABIL

    Jabil is a publicly traded electronics manufacturing services company founded in 1966 with 135,000 employees. The company provides design, engineering, and manufacturing services across multiple industries including healthcare.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd. is a publicly traded Taiwanese medical device company founded in 1988. The company manufactures and distributes healthcare monitoring and diagnostic equipment.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a publicly traded German healthcare company founded in 1996 with 108,165 employees. The company provides dialysis products, services, and healthcare solutions globally.

    ABBOTT

    Abbott is a publicly traded American healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, medical devices, diagnostics, and nutritional products.

    LINDE PLC

    Linde PLC is a publicly traded British industrial gases and healthcare company founded in 1879 with 65,034 employees. The company supplies gases, equipment, and services to healthcare and other industries.

    RESMED

    ResMed is a publicly traded medical device company founded in 1989 and headquartered in the United States. With 10,600 employees, the company manufactures cloud-connected medical devices for respiratory care and patient monitoring.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch technology company founded in 1891 with 64,317 employees. The company manufactures healthcare equipment, consumer electronics, and lighting solutions.

    GE HEALTHCARE

    GE Healthcare is a publicly traded American healthcare technology company founded in 2022 with 54,000 employees. The company provides medical imaging, monitoring, and diagnostic equipment and services.

    A&D HOLON HOLDINGS COMPANY, LIMITED

    A&D Holon Holdings Company, Limited is a publicly traded Japanese medical device company founded in 1977 with 2,480 employees. The company manufactures and distributes healthcare monitoring and diagnostic equipment.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a publicly traded British medical technology company founded in 1978 with 10,910 employees. The company manufactures ostomy care, continence care, and wound care products.

    AMEDISYS

    Amedisys is a privately held American healthcare company founded in 1982 with 19,000 employees. The company provides home health, hospice, and personal care services.

    INVACARE CORPORATION

    Invacare Corporation is a privately held American medical device company founded in 1885 with 2,800 employees. The company manufactures mobility and respiratory care products for patients.

    SUNRISE MEDICAL

    Sunrise Medical is a privately held American medical device company founded in 1978 with 4,470 employees. The company manufactures and distributes mobility and accessibility products for patients.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 3566.1 Million · 8.7% wtd CAGR ·
    North America
    ~USD 3582.1 Million · 7.8% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    UKUSD 25398 Million
    GermanyUSD 40836.4 Million
    FranceUSD 20990.71 Million
    ItalyUSD 11551.41 Million
    SpainUSD 8249.42 Million

    Country market size visualization

    UK
    USD 25398 Million
    Germany
    USD 40836.4 Million
    France
    USD 20990.71 Million
    Italy
    USD 11551.41 Million
    Spain
    USD 8249.42 Million

    Reasons to Buy this Report

    • Country-Level Market Insights : Access detailed market sizing and forecasts for key European markets including Germany, UK, France, Italy, and Spain, enabling targeted market entry and expansion strategies specific to each country's healthcare landscape.
    • Competitive Positioning Data : Understand Europe's market dynamics relative to global trends, with regional CAGR of 6.6% versus global 8.9%, helping identify competitive advantages and market saturation levels across European territories.
    • Regulatory & Reimbursement Framework : Gain insights into European healthcare regulations, reimbursement policies, and medical device standards that directly impact ventilator market adoption, pricing strategies, and go-to-market approaches.
    • Demographic & Clinical Trends : Leverage data on Europe's aging population, prevalence of chronic respiratory conditions, and healthcare system preferences for home-based care to identify high-potential patient segments and market opportunities.
    • Strategic Investment Guidance : Make informed investment and partnership decisions with comprehensive market forecasts through 2030, identifying growth corridors and emerging opportunities in Europe's $492.5 million ventilators market by end-period.

    Frequently asked questions

    What is the market size of Ventilators in home healthcare?

    Ventilators in the home healthcare market were valued at $357.5 million in 2025 and are projected to reach $492.5 million by 2030.

    What is the growth rate for Ventilators?

    Ventilators are expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2030.

    Why are Ventilators important in home healthcare?

    Ventilators enable patients with chronic respiratory conditions to receive necessary respiratory support while maintaining independence and quality of life in their home environments.

    What factors are driving Ventilators market growth?

    Ventilators growth is driven by technological advancements, an aging population, rising respiratory disease prevalence, and healthcare systems' shift toward cost-effective home-based care models.

    What patient populations benefit from home-based Ventilators?

    Ventilators serve patients with COPD, neuromuscular disorders, post-acute care needs, and other chronic respiratory conditions requiring long-term respiratory support.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global home healthcare market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the home healthcare market. The primary sources from the demand side include home healthcare service providers and home users. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Home Healthcare Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global home healthcare market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global home healthcare market was split into various segments and sub-segments based on:

    • List of major players operating in the product market at the regional and/or country level
    • Product mapping of home healthcare providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from home healthcare (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global home healthcare market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Home Healthcare Market

    Data Triangulation

    After arriving at the overall size of the global home healthcare market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Home healthcare refers to the medical attention, care, and support provided to patients at their residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at a patient’s home.

    Stakeholders

    • Home Healthcare Equipment Manufacturers
    • Home Healthcare Service Providers
    • Home Health Software Vendors
    • Nursing Service Providers
    • Wound Care Product Manufacturers
    • Pregnancy Care Product Manufacturers and Service Providers
    • Supportive Care Product Manufacturers and Service Providers
    • Diagnostic Companies
    • Research & Development (R&D) Companies
    • Business Research and Consulting Service Providers
    • Medical Research Laboratories
    • Venture Capitalists

    Report Objectives

    • To define, describe, segment, and forecast the global home healthcare market by product, service, indication, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as acquisitions, product launches & approvals, and expansions
    • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Get the Full Home Healthcare Market Report

    Full forecast, segment splits, and company analysis for all Home Healthcare Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status